Get the Stockscreener App
57.33
0.02%
-0.01
After Hours:
57.33
Halozyme Therapeutics Inc Stock (HALO) Latest News
Shaker Investments LLC OH Grows Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
State of Alaska Department of Revenue Buys 31,670 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Halozyme Therapeutics (HALO) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
abrdn plc Invests $6.15 Million in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Jennison Associates LLC Acquires Shares of 15,291 Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
WCM Investment Management LLC Lowers Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Zacks Research Issues Pessimistic Outlook for HALO Earnings - MarketBeat
Advisors Preferred LLC Purchases Shares of 42,162 Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Stephens Investment Management Group LLC Reduces Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Financial Advocates Investment Management Purchases New Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Insider Selling: Halozyme Therapeutics, Inc. (NASDAQ:HALO) Director Sells 5,000 Shares of Stock - MarketBeat
Tempus Wealth Planning LLC Buys Shares of 5,538 Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Boston Trust Walden Corp Buys 191,465 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Short Interest Update - MarketBeat
Halozyme Therapeutics' (HALO) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Hodges Capital Management Inc. Acquires 12,410 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Halozyme Stock Climbs Back After 2024 Sneak Peak As Earnings Loom - MSN
Transcript : Halozyme Therapeutics, Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-13-2023 08 - Marketscreener.com
Insider Sell: Jeffrey Henderson Sells 5,000 Shares of Halozyme T - GuruFocus.com
Halozyme Earnings Alert: Key Q4 and FY2024 Results Coming February 18Details Inside - StockTitan
Verity Asset Management Inc. Raises Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Demystifying Halozyme Therapeutics: Insights From 8 Analyst Reviews - Benzinga
Swedbank AB Trims Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Koa Wealth Management LLC Boosts Stock Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Foster & Motley Inc. Purchases 12,630 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
J&J gets positive EU opinion for subcutaneous Rybrevant (HALO:NASDAQ) - Seeking Alpha
Halozyme Therapeutics Says Non-Small Cell Lung Cancer Treatment Gets Positive Opinion in Europe - Marketscreener.com
CHMP Issues Positive Opinion for Subcutaneous RYBREVANT®(amivantamab) Co-Formulated with ENHANZE® for the Treatment of Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer - Marketscreener.com
Revolutionary 5-Min Cancer Treatment Nears EU Approval: Halozyme's Tech Slashes Patient Side Effects by 80% - StockTitan
Hantz Financial Services Inc. Decreases Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Mount Yale Investment Advisors LLC Reduces Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Why Halozyme Therapeutics (HALO) is a Top Value Stock for the Long-Term - Yahoo Finance
High Growth Tech Stocks To Watch In January 2025 - Yahoo Finance
Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term - Yahoo Finance
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Might Not Be As Mispriced As It Looks - Simply Wall St
If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now - MSN
Why Halozyme Therapeutics (HALO) is a Top Momentum Stock for the Long-Term - Yahoo Finance
7,652 Shares in Halozyme Therapeutics, Inc. (NASDAQ:HALO) Acquired by SWP Financial LLC - MarketBeat
Janney Montgomery Scott LLC Boosts Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
Marshall Financial Group LLC Invests $1.53 Million in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat
(HALO) Investment Report - Stock Traders Daily
HALO Raises 2025 Financial Guidance, Keeps 2024 View, Stock Up - MSN
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Bought by Diversify Wealth Management LLC - MarketBeat
2.27%
5.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):